A novel human anti-syndecan-1 antibody inhibits vascular maturation and tumour growth in melanoma

These findings highlight the role of syndecan-1 as a potential therapeutic target in melanoma and ovarian carcinoma and provide a new tool able to block vessel maturation, one of the mechanisms that underpin the angiogenic process essential for solid tumour growth.